Skip to content
★ Sign in to follow
SK

Shu Kwong Ngai

CFO
IGC Pharma, Inc.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 26 Aug 2013 for IGC Pharma, Inc..

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Shu Kwong Ngai: trading record in brief

Our data holds just one disclosure by Shu Kwong Ngai, dated 26 August 2013, reporting an open-market purchase in IGC Pharma, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Shu Kwong Ngai

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Interim CFOExecutivesIGC Pharma, Inc.
    0SEC
    43,100 shares0Common stockSEC:0001185185-13-001908:0
    Canonical exit: 18 Jul 2013 (T+90)

1 of 1 declaration